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Aim: Young people with psychosis have higher rates of obesity, premature cardiovascular
disease, and death compared to non-psychotic peers in the general population due to
changes in metabolic regulation linked to antipsychotic medication and adverse health risk
behaviors. The aim of this paper is to outline the development, implementation, and
evaluation of a combined 12-week exercise and health behavior intervention delivered as
part of an Early Intervention in Psychosis (EIP) routine service, within the UK.
Methods: Participants (n = 27) completed a 12-week combined intervention program,
engaging in weekly, 90-min sessions comprising a healthy behavior education session
(45 min), followed by a facilitated exercise session (45 min). Anthropometric data from
participants (n = 26) were collected at baseline, 12 weeks, and 12 months post-
intervention. Health behaviors and clinical measurements were assessed at baseline
and 12 months.
Results: Mean baseline data suggests participants were at an increased health risk on
entry to the program, with elevated values in mean body mass index (BMI; 70%
overweight/obese), waist circumference, resting heart rate, and triglycerides. Fifty
percent reported smoking daily, 64% ate < 5 fruits/vegetables per day, and 52% of
participants were prescribed highly obesogenic antipsychotic medications (i.e.,
Olanzapine). At 12 weeks and 12 months, no changes were observed in mean BMI,
waist circumference or any other clinical variable (p > 0.05). At 12 months, participants
reported a positive impact on health behaviors including improved diet, increased physical
activity levels, and cessation of substance use (n = 2), alcohol use (n = 2), and smoking
(n = 4). Focus groups captured participant experiences, engagement with and satisfaction
with the program, including challenges/barriers to program adherence.
Conclusions: The 12-week exercise and health behaviors program supported
participants to attenuate their physical health risk which was sustained at 12-monthn.org October 2020 | Volume 11 | Article 5776911
Abbreviations: CVD, Cardiovascular D
Psychosis; FEP, First Episode of Psychosi
NHS, National Health Service; NICE, Na
Excellence; PA, Physical Activity; PHE
Supporting Health and Promoting Exercis
Quality-Adjusted Life Years; UK, U
Health Organization.
Smith et al. Effectiveness and Implementation of SHAPE
Frontiers in Endocrinology | www.frontiersifollow-up. Self-reported positive health behavior changes are likely to have contributed to
the prevention of excessive weight gain in this high-risk period. The evaluation was
designed to have validity for a “real world EIP setting” and reflect the complexity of delivery
to this participant group. Evaluation findings influenced subsequent commissioning of the
physical health intervention as an ongoing element of routine EIP care within the
participant site.Keywords: early psychosis, health risk behaviors, exercise, cardiometabolic risk, combined exercise and dietary
intervention, implementation researchINTRODUCTION
Individuals with serious mental illness (SMI) have reduced life
expectancy compared to non-psychotic peers primarily due to
cardiometabolic disorders (1). Multiple etiological factors
increase the risk of premature mortality in SMI including
metabolic disturbance from second-generation antipsychotic
medications (2, 3), adverse health behaviors (4, 5), and
alterations in cardiometabolic, immune, and hepatic-pituitary-
adrenal systems (6). Young people, with limited previous
exposure to antipsychotic agents, appear to be particularly
susceptible to rapid and pronounced weight gain when
antipsychotic medication is initiated. Approximately, two-
thirds of individuals with first episode psychosis (FEP) will
experience clinically significant weight gain (by ≥ 7%) during
the first 12 months of treatment (7). Propensity to cause weight
gain differs between antipsychotics but none are weight neutral
(2). Olanzapine is associated with the largest weight effects and
higher doses are associated with greater cardiometabolic
abnormalities (8). Weight gain is a common unwanted side
effect of antipsychotic medication but can also be associated
with other adverse lifestyle factors, including sedentary lifestyle,
poor diet and unhealthy food habits, as well as an underlying
genetic susceptibility to weight gain (9). Antipsychotic
medications are also known to impair glucose metabolism,
increase cholesterol and triglyceride levels and cause arterial
hypertension, leading to metabolic syndrome and a higher risk of
diabetes and cardiovascular disease (CVD) (10). Consequently,
there has been a growing interest in interventions to control or
attenuate weight gain and increased risk of metabolic syndrome
to prevent diabetes and CVD in FEP.
Specific targets have been identified for prevention, screening,
and treatment of diabetes and CVD in SMI, including programs
to address obesity, smoking, hypertension, hyperlipidemia, and
sedentary behavior (5, 11–14). Clinical Guidel ines
(CG155,178,185) and a Quality Standard (QS80) from the
National Institute for Health and Care Excellence (15)
recommend systematic physical health screening andisease; EIP, Early Intervention in
s; KBIM, Keeping the Body in Mind;
tional Institute for Health and Care
, Public Health England; SHAPE,
e; SMI, Serious Mental Illness; QALY,
nited Kingdom; WHO, World
n.org 2monitoring for CVD risk, particularly for individuals
prescribed antipsychotics, and recommend the use of
combined health behavior interventions focused on healthy
eating, physical activity (PA), and smoking cessation.
Research has shown a positive impact of physical health
screening and intervention for participants with SMI and FEP
on health risk behaviors, weight management, and physical
health outcomes, findings which should decrease risk of CVD
(16–25). Other intervention studies found no positive impact on
weight and other long-term cardiovascular risk factors (13, 26,
27) including a large-scale study with schizophrenia and
schizoaffective disorder which included FEP patients (28).
Despite a growing body of evidence regarding the efficacy of
physical health screening and interventions, Deenik et al. (29)
suggested it is not sufficient to define policy aims targeting
physical health, relying on the results of subsequent efficacy
studies. Implementation research is needed to help practitioners
develop, implement, and deliver effective real-world
interventions in routine clinical practice which considers social
determinants of health (funding, transport, social support
networks) which may inhibit access to quality health care
services (30).
Efforts to improve physical health in SMI patients have
encountered patient and service-level barriers to implementation
of routine physical healthcare screening, monitoring, and
intervention. Patient-level barriers are both practical (money to
buy clothing/equipment, transport challenges) and psychological,
including psychotic symptoms, anxiety, low motivation, and self-
efficacy (31, 32). Service-level barriers include lack of resources for
equipment purchase, access to appropriate facilities, staff capacity,
leadership engagement, organizational change, and financial
policy strategies to support adoption and scaling up of
successful intervention programs (33, 34). Gaughran et al. (26)
concluded: “The search for effective, pragmatic physical health
interventions deliverable in health care services remains”. A
pragmatic approach, which considers barriers, social
determinants of health and enablers of initial and ongoing
participation, assumes particular importance when developing
interventions for young people with psychosis (30–32). Further
research is needed on effective strategies for program design and
guidance for mental healthcare teams to support implementation
and delivery of routine health behavior modification programs
(35–37). This study comprised two key aims: (a) to document the
context and factors influencing design, implementation, and
delivery of the intervention, and (b) to evaluate the effectivenessOctober 2020 | Volume 11 | Article 577691
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reducing adverse health behaviors that increase risk for
cardiometabolic disease and premature mortality in an
FEP population.MATERIALS AND METHODS
A team of healthcare professionals, researchers and service users
were involved in design, implementation, and delivery of the
“Supporting Health And Promoting Exercise” (SHAPE) program.
Charitable funding from The Health Foundation funded
intervention development, implementation, and evaluation.
Evaluation employed an effectiveness-implementation hybrid
design (35, 38) to assess the implementation of the SHAPE
program in routine EIP clinical practice.
Intervention Design and Implementation
The program team, supported by an EIP service user reference
group, met regularly to design the intervention and delivery
strategy. Discussions were an iterative process to agree
educational and exercise program content, location and mode
of delivery, assessment of clinical data and health risk behaviors,
staff and peer worker roles, branding/logo for the program, and
recruitment of participants. It was agreed that an evidence-based
approach would be to customize a successful FEP intervention
model established within routine EIP care called the “Keeping
the Body in Mind” (KBIM) intervention, developed and
evaluated by the Bondi EIP service in Sydney, Australia (21,
22). Utilizing this as a framework, the team customized the
program to address key factors and social determinants of health
associated with implementation in UK EIP service setting.
Key program factors included the need for the intervention
environment to foster a positive social identity and social
identification (39). Social identity, defined as a person’s sense
of who they are within a group or group membership, has been
shown to be a key mechanism underpinning the effectiveness of
group-based exercise and weight management programs (39).
Social identification, a person identifying themselves as a group
member, has been found to lead to greater subsequent effort in a
group task (40). Participants were provided with a program t-
shirt, drinks bottle, pedometer, and tape measure embossed with
the SHAPE logo to foster social identity and identification with
the group. The program was delivered at a university-
community fitness center, instead of a clinical setting, to
provide social engagement with other young people in an age-
appropriate environment while still providing a clinical and
research infra-structure (41).
Behavior modification, social support, and behavior shaping
have all been shown to improve intervention effectiveness in
SMI, so were embedded within the program design (11, 42).
Social support has been shown to be a key component
maximizing weight management program retention (42);
therefore, we employed university students to support
participants through group exercise sessions and to engage
with participants in the fitness center outside of the formalFrontiers in Endocrinology | www.frontiersin.org 3SHAPE program on request. Two EIP peer support workers
were recruited to support participant engagement and address
and allay concerns about attendance and expectations. Peer
support was also encouraged through group exercise sessions
and team activities. To extend social support outside the
program (42), a carers’ evening was incorporated into the
program schedule to provide information about the SHAPE
program, an opportunity to view the facilities, and an
education session targeting family well-being and healthy
eating followed by an optional 3-km walk using pedometers.
Access to transport and program accessibility, as well as
suitable attire and footwear, were identified as potential
barriers to participation (32). The program was delivered at a
city center location easily accessible to buses and trains, and/or
parking. Participants were encouraged to make their own travel
arrangements; however, transport was provided by EIP staff or a
community driver when required. Individuals unable to afford
suitable exercise attire were supported financially by local
charitable grant funding or personal welfare budget funding to
reduce potential self-stigma and group marginalization. Mental
health nurses from EIP oversaw program delivery and monitored
mental and physical well-being and social functioning and fed
back observations at weekly EIP team meetings. This close
working afforded EIP teams the opportunity to identify and
address individual barriers to attendance.
Maintenance of health behaviors and long-term sustainability
were identified as key indicators of success. Components to
effectively transition participants toward autonomous decision
making about their physical health, including goal setting,
practical strategies for food shopping, improving PA self-
efficacy, and access to local health and fitness services were
embedded within the program. Exercise program design was
grounded using aspects of self-determination theory (43, 44),
including key strategies structured to foster PA self-efficacy and
improve perceived competence by offering a range of mastery
experiences with education about monitoring exercise intensity
and safe exercise progression (45). It was important to develop
independent engagement with exercise during the program. To
facilitate this, we offered an informal SHAPE session which
allowed members a dedicated time to meet socially and
exercise together. Toward the end of the program, care
coordinators explored local provision to support transition to
local fitness facilities for continuation of participants’ exercise
regimens at program termination. EIP care planning included a
review of program outcomes and how these could be maintained
through continued SHAPE program attendance or using
alternative local exercise options. SHAPE participants were
offered a free gym membership for 12 months at the university
fitness center.
Combined Exercise and Health Behavior
Intervention
The SHAPE program was delivered as one component of the
routine EIP care package. The program was a combined exercise
and health behavior intervention delivered over a 12-week period
in a weekly supervised group setting. Educational and supervisedOctober 2020 | Volume 11 | Article 577691
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participants’ understanding of how health behaviors impact
short- and long-term physical health. Educational sessions
included topics on: healthy eating (21, 37), substance avoidance
(drugs and alcohol plus smoking cessation) (37, 46–48),
mindfulness (49) and personal care (sleep management) (50,
51), sexual health (52), dental hygiene (53), and goal-setting
(54). A trained nutritionist delivered three education sessions
focused on healthy eating (5 fruit/vegetables per day, a balanced
diet, portion sizes), menu planning, shopping lists, eating out and
healthy snacking designed to enable participants to make healthier
food and drink choices to help off-set weight gains. Specialist
nutrition experts leading these sessions were shown to have the
greatest impact on weight management and cardiometabolic risk
reduction in people with SMI (55). Nutrition sessions were
designed to be interactive and were supported with leaflets, a
snack tasting session, and a free healthy eating cookbook.
Participants were offered one-to-one nutrition support sessions
following SHAPE program completion.
Following educational sessions, participants engaged in a 45-
min exercise session led by qualified fitness experts and
supported by university students. Exercise education included:
how to use fitness equipment, how to self-monitor exercise
intensity and progression, and appropriate exercise training
techniques (56). Activities included: circuit training,
cardiovascular exercise, weight training, Tai Chi, yoga, Pilates,
power walking, and small team games (badminton, basketball
and handball). Exercise sessions were designed to: a) educate
participants on how to exercise safely and effectively; and b)
improve PA self-efficacy and autonomous motivation by using a
variety of exercises in different settings (fitness equipment, groupFrontiers in Endocrinology | www.frontiersin.org 4training, small team games) (57). Utilizing a broad range of
mastery experiences (opportunities to successfully achieve a
goal), vicarious experiences (witnessing someone who is
similar performing a task), and positive verbal persuasion
(providing feedback on task performance) during exercise may
improve self-efficacy and influence sustained behavior change
(45, 58). Perceived variation of exercises with a range of tasks in
different social contexts may improve individual’s felt experience
and perception leading to increased autonomous motivation (59,
60). Table 1 highlights the SHAPE 12-week program schedule.
The program was delivered to five separate cohorts over a 12-
month period. Delivery to multiple cohorts allowed for “real-
time” participant feedback to modify the program. Focus groups
were utilized to capture participant experiences, engagement and
satisfaction with the program, including challenges/barriers to
program adherence.
Participants
Individuals with FEP, from a countywide EIP service, comprising
two teams covering separate geographical catchment areas, were
invited to participate in the program. FEP is defined as the first
time a person experiences a combination of symptoms known as
psychosis. In the UK, EIP services provide support typically for
up to the first three years after psychosis onset (61). Clinical
diagnosis was determined by a team consultant psychiatrist
during routine psychiatric assessment using International
Classification of Diseases (ICD)-10 (62) criteria for a
psychotic disorder. Participant eligibility was determined by a
physical health lead nurse in consultation with case managers
and individual service users, in the context of routine
individualized care planning. Service users aged under 16 yearsTABLE 1 | SHAPE 12-week education and exercise session program schedule.
Session Health Behavior Topic Exercise Session Content Supporting Tools
1 Introduction to SHAPE Orientation to Fitness Center Baseline assessment
Tape measure
SHAPE T-shirt
2 Goal setting Cardiovascular training session Goal setting
Monitoring exercise intensity
3 Healthy Eating:
Healthy Diet and Portion Sizes














Healthy Snack Tasting Session




8 Healthy Minds: Mindfulness Yoga or Pilates
9 Small Team Games: Badminton, Basketball, handball
10 Healthy Eating: Menu Planning, Store Cupboard
Items, and Shopping Lists
Tai Chi Shopping Lists
11 Healthy Body:
Dental and Sexual Health
Designing your own workout program
Open exercise sessions
Individualized workout program
12 Goal setting, Post-intervention assessment, and
Focus Group
Open exercise sessions Goal settingOctober 2020 | Volume 11 | Article 577691
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symptoms were not yet well-controlled on antipsychotic
medication were unable to join the program. Service users who
were unable to join, declined to attend, failed to engage, or
dropped out from the program were given the opportunity to
attend a later SHAPE cohort when their mental health had
stabilized or other factors inhibiting attendance and
participation had been resolved.
Participants provided voluntarily written consent for their
routine clinical data to be used in the study. This study
conformed to the principles of the Helsinski declaration and was
granted ethical approval by the University of Worcester Research
Ethics Committee (REC approval number: UWEC2014JS1).
Procedures
Assessment of Cardiometabolic Risk and Health
Risk Behaviors
On acceptance onto EIP caseload, participants had a routine
physical health assessment conducted by a mental health nurse.
Clinical measures included: BMI, waist circumference, resting
heart rate and blood pressure, glycated hemoglobin (HbA1c),
fasting plasma glucose (FPG), blood lipids, and prolactin. Blood
lipids included measures of total cholesterol (TC), low-density
lipoprotein (LDL-C), high-density lipoprotein (HDL-C), and
triglycerides. Abdominal adiposity was assessed using waist
circumference where measurements were made at the
approximate midpoint between the lower margin of the last
palpable rib and the top of the iliac crest (63). Blood tests to
determine HbA1c and/or FPG, blood lipids, and prolactin were
requested by the patients’ general practitioners and conducted by
NHS pathology departments. All blood data were collected from
electronic patient records. Physical health markers were assessed
against NICE (15) criteria to determine risk levels for
cardiovascular and metabolic disorders. All clinical measures
were assessed at baseline and 12 months post-intervention as
part of routine clinical care monitoring.
Health risk behaviors were assessed using self-reported
measures for diet (eating > 5 fruit/vegetables per day;
equivalent to 400 g a day based on 80 g portions) (64), tobacco
use (current smoker or within last 6 months), alcohol use
(Alcohol Use Disorders Identification Test) (65), substance use
(yes/no response), and PA levels (Exercise Vital Sign (EVS) (66).
Sedentary behaviors were determined as engaging in PA less than
< 90 min of moderate PA per week (56). Anthropometric data
were collected at week 1, immediately post-intervention (week
12), and 12 months post-intervention.
Program Evaluation
Attendance monitoring and semi-structured focus group
discussions generated qualitative feedback as part of an
iterative process to develop and refine the SHAPE program to
meet user needs. Program adherence was monitored by
recording attendance and individuals’ reasons for non-
attendance and disengagement. Barriers to attendance were
recorded and problem solved in SHAPE and EIP team
meetings to support program uptake and adherence.Frontiers in Endocrinology | www.frontiersin.org 5Focus group discussions were conducted after the last exercise
session of the 12-week SHAPE program. The purpose of the focus
groups was to provide participant observations and feedback on
program participation to support evaluation and validate findings
through use of participant quotes. Participants were invited, but
not required to attend, and were assured it would not affect or
influence program participation, continued use of the fitness
facilities, or their EIP care or treatment. Focus groups were semi
structured using open ended questions exploring participant
reasons for joining SHAPE, experiences of the program, barriers
and facilitators affecting participation, impact of the program on
weight, PA levels, health behaviors and general functioning as well
as suggestions for program change/improvement. Focus groups
were conducted by the program lead, a clinical psychologist, who
was not involved in the running of the SHAPE program but may
have been known to some participants from involvement in their
care within the EIP service. A facilitator, known to participants,
managed recording equipment and their presence was designed to
reduce participant anxiety by providing a familiar face. Focus
groups lasted between 45 and 60 min and were audiotaped and
transcribed verbatim to support coding and classifying to identify
main themes and sub themes (67).
Data and Program Analysis
Baseline analyses were conducted for the total population and by
gender. Repeated-measures analysis of variance was performed
to determine differences over time for anthropometric data.
Paired sample t-tests were used to determine significant
differences from baseline to 12 months post-intervention for
clinical markers. Data were analyzed using IBM SPSS Statistics
for Windows, Version 25.0 (Armonk, NY: IBM Corp). Results
are reported as the mean ± standard deviation (SD) and/or as a
percent of the population sample. Probability values < 0.05 were
considered significant.
Transcribed text from the focus group data were deductively
analyzed drawing on pre-determined program factors including
program location and environment, program design, program
content, social support and impact (68). Transcripts were
reviewed for content and coded for correspondence with key
program factors and any new themes that emerged inductively
from the data.
Key measures for program cost evaluation included: 1)
percent change in body mass (69) and subsequent
improvement in quality-adjusted life years (QALY), where the
cost of Quality of Life Years has been shown to reduce if patients
can (a) avoid 7% weight gain and (b) stop smoking (15); and 2)
percent change in prevalence (based on BMI change) of CHD
and Type 2 diabetes (70).RESULTS
Participant Recruitment and Program
Adherence
Figure 1 provides program enrollment, program attendance, and
post-intervention attendance figures. Figure 2 shows 59%October 2020 | Volume 11 | Article 577691
Smith et al. Effectiveness and Implementation of SHAPEFIGURE 1 | SHAPE Program CONSORT Diagram.FIGURE 2 | Mean weekly SHAPE program attendance.Frontiers in Endocrinology | www.frontiersin.org October 2020 | Volume 11 | Article 5776916
Smith et al. Effectiveness and Implementation of SHAPE(n = 67) of invitees did not attend the program. Forty-one
percent (n = 46) attended the first SHAPE program session.
Week 5 was a critical point for program adherence, where
participants attending up to this point were more likely to
complete the whole program.
Participant Characteristics and Clinical
Outcomes
Twenty-seven participants aged 18–37 years completed the
SHAPE program. Only 26 participants completed the 12-week
post-intervention assessment. Completers were those
participants who attended a minimum of five sessions. Table 2
provides demographics, diagnosis, and treatment characteristics
by sex for these 26 participants.Frontiers in Endocrinology | www.frontiersin.org 7Tables 3 and 4 provide anthropometric and cardiometabolic
data at 12-week and at 12-month follow-up. Mean baseline
data (n = 26) suggest participants were already at an increased
health risk due to elevated values in mean BMI (81% were
overweight or obese), waist circumference (73% at increased
risk), resting heart rate (64%), and blood pressure (58% pre-
hypertensive; 27% hypertensive), and 50% met the criteria for
dyslipidemia. Analysis of health behavior data showed that
39% had a sedentary behavior, 73% ate < 5 fruits/vegetables
per day (~400 g equivalent), 46% reported smoking daily,
35% consumed alcohol, and 12% engaged in drug use. Fifty-
two percent were prescr ibed the most obesogenic
antipsychotic medications (Clozapine and Olanzapine).
Over 85% had elevated resting blood pressure (> 120/
80 mm Hg).
At 12-week post-intervention (n = 26), there were no
statistical changes in mean body mass, BMI, or waist
circumference (p > 0.05). Seven participants maintained weight
(±1 kg). Seven participants decreased weight (1.3–8.4 kg); four of
whom lost > 5% of their body weight. Twelve participants
increased weight (1.3–9.6 kg). Three participants (11.5%)
exceeded the Lester UK guidelines of > 5 kg within 3 months
(71), of whom, two (8.0%) exceeded the cut off for clinically
meaningful weight gain > 7% of their bodyweight (16). Both
participants were prescribed Olanzapine.
At 12-month post-intervention (n = 11), there was no
statistical change in mean BMI, waist circumference, or any
other clinical variable (p > 0.05). Two participants maintained
weight (±1 kg). Three participants decreased weight (−2.2 to
6.6 kg); 2 of whom lost > 5% of their body weight. Six
participants gained 1.3 to 3.4 kg. One individual (9.0%), taking
Olanzapine, exceeded > 7% of their bodyweight and the Lester
UK > 5-kg threshold. Multivariate analysis revealed no change
over time for body mass (F =1.009; p = 0.403, hp2 = 0.183), BMI
(F = 0.792; p = 0.482; hp2 = 0.150), or waist circumference (F=
0.165; p =0.851, hp2 = 0.40).
At 12 months, positive impacts on health risk behaviors
included: 5 (45%) participants eating > 5 fruit/vegetables daily
(~400 g equivalent), 1 (9%) ceased substance use, 2 (18%) ceased
alcohol use, 4 (36%) ceased smoking, and 4 (36%) were
less sedentary.TABLE 2 | Demographics, diagnosis, and treatment characteristics by sex.
Characteristic Total (n = 26) Males (n = 18) Females (n = 8)
Age (y) M(SD) 27.7 (5.1) 24.0 (3.9) 25.7 (5.4)
Duration since onset
0–6 months 10 (38.5%) 6 (33.3%) 4 (50.0%)
>6 months 16 (61.5%) 12 (66.7%) 4 (50.0%)
Ethnicity (%)
White British 22 (84.6%) 16 (88.9%) 6 (75.0%)
Asian 2 (7.6%) 2 (11.2%) 0
Chinese 1 (3.8%) 0 1 (12.5%)
Undeclared 1 (3.8%) 0 1 (12.5%)
Primary SCID diagnosis
FEP 11 (42.3%) 7 (38.9%) 4 (50.0%)
Schizophrenia 11 (42.3%) 9 (50.0%) 2 (25.0%)
Bipolar 2 (7.7%) 1 (5.6%) 1 (12.5%)
ARMS 1 (3.8%) 0 1 (12.5%
Non-organic 1 (3.8%) 1 (5.6%) 0
Antipsychotic Treatment (%)
No medication 1 (3.8%) 1 (5.6%) 0
Aripiprazole 3 (11.5%) 1 (5.6%) 2 (25.0%)
Clozapine 10 (38.5%) 10 (55.6%) 0
Olanzapine 5 (19.2%) 2 (11.1%) 3 (37.5%)
Quetiapine 5 (19.2%) 2 (11.1%) 3 (37.5%)
Risperidone 2 (7.7%) 2 (11.1%) 0
Antidepressant Treatment (%)
Citalopram 3 (11.5%) 2 (11.1%) 1 (12.5%)
Sertraline 2 (7.7%) 1 (5.6%) 1 (12.5%)
Venlafaxine 2 (7.7%) 0 2 (25.0%)
Fluoxetine 3 (11.5%) 1 (5.6%) 2 (25.0%)TABLE 3 | Comparison of anthropometric measurements at baseline, 12 weeks, and 12 months [M(SD)].
12-week post-intervention
Variable N Baseline 12 weeks Baseline to 12-week post
Body mass (kg) 26 94.4 (23.1) 95.1 (23.4) t = 0.811, p = 0.43
BMI (kg.m−2) 26 30.7 (7.2) 31.0 (7.4) t = 0.967, p = 0.34
Waist circumference (cm) 26 98.1 (17.0) 99.2 (16.8) t = 0.757, p = 0.46
12-month post-intervention
Variable N Baseline 12 weeks 12months Baseline to 12-month post
Body mass (kg) 11 99.0 (30.8) 100.0 (31.8) 100.8 (31.2) F = 0.551, p = 0.50
BMI (kg.m−2) 11 33.0 (9.6) 33.3 (9.8) 33.7 (9.9) F = 0.584, p = 0.48
Waist circumference (cm) 10 98.2 (21.0) 99.6 (23.7) 99.7 (25.2) F = 0.258, p = 0.75October 2020 | Volume 11 | Article 577691
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Focus group quotes to illustrate main program factors are
presented within Table 5. One main theme: “impact on wider
functioning”, and two subthemes: “feeling better/sense of
accomplishment” , and “program commitment” , were
constructed inductively from the data during analysis.DISCUSSION
The current study sought to implement and evaluate a combined
exercise and health behavior intervention within routine care
practice in a UK EIP service. The SHAPE intervention represents
the first UK evaluation of a combined exercise and health
behavior intervention specifically targeting FEP to develop
positive health behaviors and improve weight maintenance.
The study showed that young people with psychosis are
already at an increased risk for CVD and metabolic disorders
at time of diagnosis, and early intervention to address their
physical health may improve health behaviors and attenuate
weight gain at 12 weeks with sustained benefits at 12-month
follow-up. The combined exercise and health behavior program
was offered as a core element of routine individual EIP care
planning, but program participation was affected by patient
choice, low motivation, geographical constraints, and intrusive
mental health symptoms including social anxiety, low mood, and
persistent psychotic symptoms.
Changes in Physical Health Outcomes
Participants in this study had elevated anthropometric and
clinical markers at baseline indicative of increased CVD risk,
likely to be linked to self-reported sedentary behavior, smoking,
poor diet, high rates of obesity (4, 5), and antipsychotic
medication (7). This aligns with previous research in the USA
and Australia which has demonstrated a high prevalence of
metabolic syndrome in people with schizophrenia at time of
diagnosis and with illness progression (~35%–40%) (72–74); and
as a consequence, an increased risk for CVD, impaired daily
functioning, and premature mortality (72, 75–77).
As far as we are aware, there are only five small-scale studies
internationally (16, 17, 21, 24, 41) which have specifically
recruited from EIP services. Our findings concur with similar
combined interventions in FEP in Australia, which alsoFrontiers in Endocrinology | www.frontiersin.org 8demonstrated attenuation of weight gain and lower BMI than
controls at 3 months post-intervention (16, 21) as well as self-
reported positive health behavior changes in PA, fitness, and diet
(21). The SHAPE intervention achieved comparable outcomes
and mitigated the expected rise in BMI and associated risks for
type 2 diabetes and CHD typically observed in an FEP cohort.
SHAPE is the first UK EIP intervention study UK to show that
effects are maintained at 12-month follow-up, which, if
sustained, would reduce associated longer-term health care and
QALY costs. Without intervention, we would expect an FEP
group to show additional weight gain over 12-month follow-up
based on FEP weight gain projections over time (7).
Two other EIP intervention studies, in Canada (17) and the
UK (24), involved an exercise training program only. Abdel-Baki
et al. (17) employed a 14-week aerobic interval training (AIT)
program and reported a decrease in waist circumference and
improvements in cardiorespiratory fitness (p < 0.05). By
comparison, SHAPE participants did not show a decrease in
waist circumference but maintained mean waist circumference at
12-week and 12-month post-intervention. Firth et al. (24)
involved a 10-week individualized supervised exercise program
but failed to show any impact on body weight, BMI, or waist
circumference although they did report improvements in
negative symptoms and social functioning post-intervention.
The latter study achieved a much higher program retention
rate (81%) than other EIP intervention studies, including this
study, but found adherence to unsupervised exercise was halved
following program cessation. PA levels decreased significantly,
and symptomatic improvements were only maintained for those
who continued to exercise at 6-month follow-up (25). The
remaining EIP intervention study in Denmark has only
published a qualitative analysis to date (41). More research is
needed to understand the sustained effectiveness of combined
health behavior modification and exercise behavior change on
weight maintenance and BMI in reducing cardiometabolic risk in
FEP (21) and how changes in exercise and health risk behaviors
may mediate these effects and can be successfully maintained in
the longer term.
The SHAPE intervention appeared to be effective in
attenuating antipsychotic induced weight gain for the majority
(75%) of participants. Just under 8% of participants at 12 weeks
and 9% at 12 months gained more than 7% of their bodyweight.
Using the Lester UK guideline criterion (71), 12% participantsTABLE 4 | Cardiometabolic risk markers and lifestyle behaviors at baseline and 12 months post-intervention [M(SD)].
Variable N Baseline 12 months Mean Change 95% CI Lower, Upper P value
Body mass (kg) 11 99.0 (30.8) 100.8 (31.2) 1.86 (7.3) −3.02, 6.7 0.42
Body mass index (kg.m−2) 11 33.0 (9.5) 33.7 (9.9) 0.7 (2.5) −1.02, 2.3 0.41
Waist circumference 10 98.2 (21.0) 99.7 (25.2) 1.5 (8.0) −4.3, 7.2 0.57
Systolic blood pressure (mm Hg) 11 121.6 (12.9) 124.2 (15.7) 2.5 (17.5) −9.24, 14.3 0.64
Diastolic blood pressure (mm Hg) 11 80.9 (8.7) 82.6 (6.7) 1.7 (10.6) −5.4, 8.9 0.60
Resting heart rate (beats.min−1) 10 86.8 (23.3) 89.9 (22.2) 3.1 (20.4) −11.5, 17.7 0.64
Total cholesterol (mmol.L−1) 6 4.3 (0.9) 4.1 (0.9) −0.2 (0.9) −1.2, 0.7 0.48
HDL cholesterol (mmol.L−1) 5 1.0 (0.2) 1.6 (1.5) 0.6 (1.5) −1.2, 2.4 0.58
Triglycerides (mmol.L−1) 2 2.4 (2.2) 2.9 (2.9) 0.4 (1.5) −5.7, 6.6 0.64
HbA1C (mmol.mol) 6 31.9 (14.6) 37.7 (9.7) 7.0 (11.4) −5.6, 19.7 0.22
Prolactin (mIU/L−1) 4 1083.5 (707.3) 433 (239.1) −650.5 (595.3) −1737.8, 436.8 0.15October 2020 | Volume 11 | Article 577691
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“it was fairly easy to get to … less than 5-minute walk from the train
station.”
“relaxed environment … not as busy as some gyms … You’re in
control of what you’re doing, and it’s just a good experience.”
“there’s other people that come at the same time, … there’s other
people working out as well, so you feel like you’re in a normal
environment.”
“Because it’s a Uni- it’s got that extra edge to it. All the students
walking around, learning, smart.”
“it’s not too early … you can travel after rush-hour…”
“… I have to travel quite a way to get here.”
“… it costs quite a lot of money to get here, so it








“it was kind of an open discussion on options we have over our
lifestyle rather than like you’re not eating this or you’re not eating that
or get out and do that! … make your own decisions based on our
recommendations … which was good.”
“Every week was different … It wasn’t the same old
thing, it was very varied.”
“I like the talking and nutrition part.”
“Yes, saying how big the portion is, you only need a
small amount where I thought you needed a lot. … Yes, the nutrition
ones were good.”
“I liked the tasting session as well, when we tried new things, healthy
snacks….”
“I also liked learning about drugs, I found it interesting.”
“new ideas from sessions before the gym.”
“I much preferred the exercise part. I already knew a
lot of what was being said. I would have preferred to
spend longer doing the sports things, but I
understand that some people found it really beneficial
so I didn’t mind.”
“At one point he suggested dips and crackers, as a
substitute for crisps and things. I noticed if you
bought a tub of dip or whatever, it would go off
within 2 days, and you have to have quite a lot of
crackers over the two days, rather than having it
once a week or twice a week, you are having to have
it quite a lot to use it all and not waste it.”
“I found mindfulness difficult to do as I was thinking
about lots of things.”








“I learnt how to use the fitness equipment. … should be alright for me
to work the machinery on my own.”
“Learning the new equipment, … getting to grips with that because
it’s something that’s alien to me.”
“I think it’s worthwhile doing it (goal setting), so you know what you’re
trying to achieve, rather than just coming in and not really having a
goal.”
“… the gym an adequate length, and we’ve got the opportunity to
stay after the session is over, so the length of that isn’t a problem.”
“using the gym facilities … particularly like the rowing
machine and treadmill.”
“Handball. … that was my favourite. That broke up the programme as
well, doing something a bit different every time, so that was quite
good.”
“My favourite activity … basketball.”
“I enjoyed Pilates, it was relaxing. Good for
strengthening the muscles.”
“ … body balance has been my favourite”
“I was worried about using the
equipment, and how to use it.”
“I actually used the gym probably for
about half an hour longer. It seemed a bit too short.”
“I found the weights difficult.”
“Pilates was okay, not really something I would
normally do.”






“The books help … something else to focus on, and to try things that
you wouldn’t ordinarily try.”
“I got given a pedometer … then I knew I supposed to have 10,000 a
day so that kind of came quite addictive then.”
“I still check my step counter all the time”
“I wouldn’t have walked this far had I not had to do it, and it (step
counter) made me increase the activity level, and walking around
outside of the times as well.”
“it (step-counter) could have been done earlier. …
we could have looked to see how much everybody
had walked, and do it week on week to see if we’ve
increased. Or do it start to end and see the
progress.”
“….an app would be really useful to log activity every
day or to say everyone get something like my fitness
pal like an app that already exists.”
Program
Engagement
“I was hesitant at first, not sure whether I would like it or not, whether
there were people there I wouldn’t get on with, so I was a bit hesitant,
but eventually said yes.
“I remember there were people waiting in the entrance on the first
week, telling us where to come and introducing us, so that was quite
handy.”
“I was a lot more unstable to start with, as the programs gone on my
mood has become more stable.”
“I was suffering from really bad anxiety and panic attacks, and I really
didn’t want to go. I really had to force myself to go, but I survived the
first time, which made me persevere.”
“sometimes, for someone with psychosis or
schizophrenia, sometimes it can be difficult to cope.”
“ the size of the group at the start was a bit
overwhelming.”
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“After the first week of doing it, I wanted to keep doing it, to keep
helping me.”
“I don’t think there is anything that would put me off from what I
experienced in the first week so if someone would drop out its












“I quite liked how it structured my day, … you feel like you’ve
accomplished something after coming and that’s good for my self-
esteem.”
“It feels good to have a constant routine coming to the gym every
Thursday. I have more energy.”
“it is good and has got me into a routine again.”
“also, the structure to your day, when I get home I feel like I’ve done
something.”
“I feel differently when I haven’t been like I feel less productive, it’s part
of my routine now.”
“once I’ve done the exercise, and I’ve done it, I feel loads better, like a
weight has been lifted, it enables me to carry on for the day, for the
rest of the week. It really motivates me, just by the fact that it lifts me.”
“…I do feel better immediately after the exercise.”
“I always feel like on Thursday is like a really happy time because I
finish SHAPE then I feel rewarded for going out and doing something
… I feel like I have accomplished something after coming and that’s
good for my self-esteem.”
“Although it got better each time, it wasn’t the nicest, but once I got
into it, into the session, it got easier and then gradually over the
weeks it got easier still.”
“the two things that have changed the most is my concentration and
mood … I was a lot more unstable to start with, as the programmes
gone on my mood has become more stable”
“Sometimes I wake up and I don’t feel like doing anything, but
because I’m committed to coming I force myself to go.”
“I didn’t feel well, but I thought I should go as it’s the last week, … I
felt better afterwards.”
“quite good having that on Thursday then I find myself going to the
gym on Friday and Saturday because it’s motivating.”
“there’s loads of things. It’s fun, it’s worthwhile doing, you make
friends, it gets you fit, helps with your motivation.”
“I think that my motivation has got better because before I … just sat
in my room at home.”
“I had to force myself to come, to make myself do it,
because I thought once I was here, I would go and
do it, but it seemed like such an effort at times to just




“it was good to start off with a chat, and see which people were with
their t-shirts on.”
“you could tell who else was in the group as well, and kind of feel
together, sense of identity.”
Social support “… I felt like I’d made a friend, and then more friends, and it was
easier than just being on your own, because you felt like you were
going with somebody.”
“as the group got smaller, you kind of got to know people better …
you had regular contact with a regular person which was nice.”
“… to see other people in your situation benefitting from the same
things as you, it’s quite reassuring.”
“the group is much better, because you can do more things. …The
group was one of the reasons I wanted to do it, because I wasn’t
really seeing anyone, so that was the main thing – to do something
that I enjoyed but also improve socially I suppose.”
“… get to know people better, and you find out you might have other
activities that you do together so, that helps and you learn things
about each other which is quite fun.”
“… you can’t do sports on your own, so the sports I enjoyed.”
“the person who I came along with grew in confidence throughout
and more importantly gained a friendship has led to the two of them
carrying on at the Gym and meeting up on a weekly basis.” (peer
support worker)
“I’ve been talking to X about membership, so then I
would have someone to go with, because I wouldn’t
do it on my own.”
“… I can go by myself. I have been to a gym outside
of this, I don’t really mind going on my own.”
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considerably lower than that observed in the Álvarez-Jiménez
et al. (16) FEP intervention study where 39% of intervention
participants had increased their baseline weight by more than 7%
at 3 months. The importance of weight maintenance to reduceFrontiers in Endocrinology | www.frontiersin.org 11the risk of all-cause mortality was highlighted by Prospective
Studies Collaboration et al. (78), stating that preventing weight
gain from 28 to 32 kg.m−2 during early middle age would yield
about 2 years of additional life expectancy. The cost of QALY has
shown to be reduced if patients can avoid a 7% weight gain (15).TABLE 5 | Continued
Program Factors Sub-Themes Participant Feedback (positive) Participant Feedback (negative)
Carer support
and feedback
“My husband helped– we changed our diet together.”
“Yes, they can see how it’s helped me, it’s improved my confidence.”
“My dad said I’ve lost weight, he usually only says that if it’s true.”
“… It has just transformed him. Not only is he back in shape – almost
to his old self – but he is so much more positive and confident. … He
is taking much more interest in his own wellbeing which is what
SHAPE is about – not just the exercise. He is looking good so we
have been clothes shopping and he taking an interest in how he
dresses … The 12 weeks are up but he remains just as motivated
which couldn’t be better illustrated by the fact that he, and another
fellow on the course, are keeping up the same routine and are still






“I haven’t eaten less, but my waist circumference has gone down,
and my BMI has gone down.”
“I have lost a stone so far, I can also feel it in my clothes.”
“The sessions have been worthwhile and I have gotten more fit and I
have lost weight.”
“My heart rate is a bit lower.”
“well I have actually put on weight but I think I have
put on muscle in my legs and my belly.”
“not everyone wants to just lose weight so like if I
said I want to get stronger then maybe you could
take arm measurements … instead of just saying you






“I am trying to eat more fruit and veg now.”
“I have cut down on eating and I am eating healthier food.”
“we try to get extra portions of vegetables into our meal, and find
new, creative ways to incorporate them … and extra fruit and things
like that.”
“because of the nutrition side of things, I’m trying to concentrate more
on healthy eating and things.”
“I did some research, and found that wheat sort of puffs you up, so
trying to cut that out.”
“I’m doing more cooking on my own now. I’m eating much more now







“I can walk quicker without losing breath. Before I’d have to walk
slow.”
“Feel fitter, easier to move around without getting out of breath.”
“I can actually run up the stairs now.”
“it’s good to have exercise as a form of release or, as I know I do feel
better if I am having a really bad day, if I exercise, the rush or
whatever you get, you feel better for like an hour or two and removes




“I was a smoker before and even though I really enjoyed smoking did
reluctantly want to stop, I have now”
“I reduced smoking from 30 a day to 5 a day over the last 2 months.”
“I just feel a bit like I have a bit more energy. I think my heart’s a lot
healthier now because like before obviously smoking and not
exercising for quite a while, I feel like my stamina is better.”
Impact on Wider
Functioning
“I am starting swimming, gym and exercise classes. The SHAPE gym
helped me get motivated.”
“now I quite like to cycle down the road … then walk the rest of the
way into town.”
“It has made me change my routine on other days as well. …. I’ve
started doing it in the morning, then setting up my day with it, just to
get that level of activity and to make me feel just a little bit better.”
“I had a car accident about 5 years ago, and my knees have been
weakened since, and I think walking here and the activities we’ve
been doing here has helped strengthen them.”
“I think that my motivation has got better because before I felt like I
was just sat in my room at home.”
“I still struggle with my fears and bad feelings. At
home I’m always so-so, when people ask me how I
am I say so-so. I haven’t noticed a big change.”
“I was struggling to continue after the weeks weren’t
taught, it was a bit more of a push to actually get
there, for me anyway.”October 2020 | Volume 11 | Article 577691
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risk of metabolic syndromes can also result in clinically
meaningful reductions in morbidity and risk of early mortality
(79). In this study, 4 participants at 12 weeks and 2 participants
at 12 months had decreased > 5% body mass. It may be plausible
to expect that reductions in body weight for these participants
could also result in corresponding reductions in morbidity and
premature mortality.
Changes in Health Risk Behaviors
Baseline self-report data identified a few adverse health risk
behaviors among participants, notably: sedentary behavior,
poor dietary intake, and smoking. Positive behavior changes in
eating, PA, smoking, and substance use were reported by several
participants at 12-month follow-up. These changes are
important as they are among the top eight risk factors (alcohol
use, tobacco use, high blood pressure, high body mass index,
high cholesterol, high blood glucose, low fruit and vegetable
intake, and physical inactivity) that account for 61% of
cardiovascular deaths and combined, account for over three
quarters of ischemic heart disease worldwide (80). The same
WHO report identified that reducing these eight risk factors
would increase life expectancy by almost five years.
Five participants reported positive changes in their eating
habits reflected in eating 400 g equivalent of fruit/vegetables daily
which is an important outcome in relation to tackling obesity
and reducing the risk of CVD, diabetes, and premature mortality.
Adequate consumption of fruit and vegetables reduces the risk
for CVD, stomach cancer, and colorectal cancer (81, 82).
Similarly, increases in PA are important in people with
psychosis who have been shown to be more sedentary (83, 84)
and, therefore, at greater risk of obesity and cardiometabolic
diseases than their non-psychotic peers (85).
Four participants ceased smoking. Cessation of and
reductions in smoking are also important as this has been
identified as the most important risk factor for poor health and
reduced life expectancy. It is the largest contributor to
preventable illnesses including cardiovascular and respiratory
diseases and explains much of the excess mortality and reduced
life expectancy of people with mental health problems (46,
86). The benefits for smoking cessation and reduction are not
just in relation to long term health risks but can also contribute
to more immediate benefits in terms of lower stress levels,
reduced financial burden associated with the costs of smoking,
and improvements in mental health (87, 88).
Alcohol use has also been identified as one of the top five
global risks for burden of disease where it is jointly responsible
for one fifth of all Disability Adjusted Life Years (DALYs) (years
of life lost due to premature death plus years of healthy life lost
due to illness and disability), and one quarter of all deaths in the
world (89). Two participants had ceased alcohol use at 12
months. Reducing use of alcohol would be expected to have a
positive impact on life expectancy by nearly 5 years (89).
Focus group participants attributed weight, exercise, and
health behavior changes to the SHAPE program and
commented on wider beneficial impacts on their mental healthFrontiers in Endocrinology | www.frontiersin.org 12including mood, motivation and functioning. Positive self-
reported health behavior changes at 12 months are likely to
have contributed to weight attenuation and other physical health
benefits observed. Limitations of the study design preclude our
ability to show definite associations between health behavior
changes and changes in weight, BMI, and other cardiometabolic
measures observed over time.
Program Engagement, Drop Out,
and Adherence
Program recruitment was time consuming and required clinical
team members to prioritize SHAPE involvement alongside other
clinical roles. Young people with psychosis can experience many
difficulties associated with their mental health including
psychotic symptoms, social anxiety, and poor motivation (32).
For some, the prospect of a group-delivered program was
particularly daunting. Feedback from participants highlighted
challenges associated with travel time and cost, group size, social
anxiety, mood instability, difficulties coping, and maintaining
motivation. Two thirds (59%) of invitees did not attend the first
session due to lack of interest, poor motivation, poor mental
health or travel concerns. Timing of program sessions was
important where participant feedback stated that anything
before 11 am was difficult, which led to scheduled sessions
being moved to late morning to support attendance. Forty-one
percent of participants dropped out of the program. This is not
unique to SHAPE and appears to be a common observation in
other EIP physical health intervention studies. STEPWISE self-
management education program (Holt et al., 2019) also found
program recruitment challenging, where 17% of recruits did not
attend any sessions and only 23% attended all seven core and
booster sessions. Abdel-Baki et al. (17) reported a drop out rate
of 36% where only 64% of their participants completed the
training program. Curtis et al. (21) reported attrition rates of 62%
for the KBIM intervention and 52% for their standard care
comparison group. In the COPUS intervention trial (41), 38%
discontinued the intervention with the majority dropping out
prior to the start or early in the program and only 23% of
participants attended the final session of their 8-week program.
Disengagement is a common challenge for EIP services and in
FEP studies and has been linked to a number of factors including
duration of untreated psychosis, symptom severity at baseline,
insight, substance abuse, and lack of family involvement (90).
Findings from the study identified the need for future program
design to be cognizant of social determinants (finance, transport,
support networks) influencing access to health care services and
sustained program engagement.
Some participants were motivated and travelled considerable
distances to attend weekly sessions, although, travel was an issue
for several participants. The EIP service serves a rural catchment
area (~630 square miles) which is challenging when identifying a
suitable program location. Holt et al. (2019) supported program
access using taxis which EIP staff found helpful but commented
that participants were unlikely to have attended without this
provision and doubted the financial sustainability in routine
practice (34). When considering program sustainability, a singleOctober 2020 | Volume 11 | Article 577691
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poorly motivated individuals; utilizing multiple locations may
increase program accessibility.
Participant Experiences of and Feedback
on the Program
Focus group feedback provided an iterative service improvement
loop and enhanced program evaluation. Participants were
positive about all aspects of the intervention and provided
helpful feedback on program environment, location, timing,
accessibility, and content and how these positively influenced
motivation and program adherence. A couple talked about the
value of the SHAPE t-shirts in creating a group identity. Several
commented on the program delivery style encouraging self-
determination and autonomy in relation to health choices, and
confidence and mastery in relation to using gym exercise
equipment. Participants commented on the different session
components particularly appreciating the variety of educational
session content and enjoyment of different group sports and
particular items of gym equipment. They specifically talked
about the value of goal setting, keeping an activity log, and the
cookbook and step counter as helpful supporting tools. One
participant suggested that step counters could have been
introduced earlier in the program to encourage goal setting,
monitor weekly activity levels and progress over the program
course. Another suggested that an app, like MyFitness Pal, could
assist with recording and monitoring activity. A number of
health benefits from the program, beyond increasing PA or
losing weight were identified. The provision of interactive
nutrition sessions, including healthy food “sampling” sessions,
encouraged participants to try new foods and consider accessible
changes to their diet. The group-based delivery of the program
reduced social isolation and encouraged group cohesion and
contact between participants, both within and outside of the
formal SHAPE sessions which was clearly valued by participants.
The program also led to reported benefits in motivation,
confidence, social anxiety, self-esteem, and smoking cessation
and a broader impact on functioning, routine, and mood. Several
participants talked about how the program had been a
springboard enabling them to take control of and sustain
health behavior changes. Participants valued family support
and feedback on observed changes in weight, confidence and
functioning. Focus group interviews also allowed exploration of
factors affecting program adherence and barriers to
participation, which were both logistical (cost, distance, and
transport ease) as well as psychological (anxiety, low
motivation, poor concentration, coping, and confidence related
to mental health). These findings are consistent with several
recent qualitative evaluations of health behavior programs with
FEP groups which identified common features that were valued
by participants and reported similar benefits from and barriers
affecting participation and adherence (31, 32, 34, 41, 91, 92).
Program Design and Implementation
Deenik et al. (29) highlighted a need for effective physical health
intervention studies with SMI to be translated into real-worldFrontiers in Endocrinology | www.frontiersin.org 13settings, suggesting that research on program implementation in
standard care practice is an essential step to translate effective
health behavior interventions into routine mental health care.
Unfortunately, there remains a “research to real-world” gap
where research innovations are rarely effectively adopted and
implemented in real-world health care settings (93), Both studies
highlighted barriers to effective implementation including poor
alignment between researchers, health care systems, and
providers. They argued that moving research “from innovation
to application” requires local input, using local options, and
developed using a sustainable approach that enables frontline
workers to continue implementation and delivery. Unlike many
previous physical health interventions which started as a
randomized clinical trial or research-based intervention, the
SHAPE program was designed, implemented, and delivered in
partnership with EIP service users, the EIP service team, and
local researchers and health care professionals. All team
members worked locally, were familiar with geography and
infrastructure challenges of a large rural county catchment
area, and aware of opportunities and local resources that could
be harnessed to maximize intervention program design
and delivery.
The customized intervention offered a coordinated, multi-
professional, health and well-being intervention program which
was designed to encourage participants to meet peer SHAPE
participants and university student “exercise buddies” within a
positive, youth friendly, socially inclusive setting. Other UK
physical health intervention programs in FEP (24) did not
include a group exercise component (42) or peer support
opportunities (94), which have been identified as important
factors in long term exercise program adherence and
maintenance. In contrast to the Australian KBIM study (21),
the SHAPE program was located at an accessible city center
location within a university-exercise setting, which was deemed
to be more normalizing than a clinical healthcare setting. Firth
et al. (24) and Larsen et al. (41) similarly elected to locate their
interventions in community fitness facilities. The delivery of
exercise interventions in a clinical setting may engender health
and safety concerns without having qualified instructors
supervising exercise as well as equipment purchase and
appropriate space concerns that might impinge on program
scope and flexibility. Mental health care services may need to
explore local resources and identify partners, such as exercise
referral schemes or other community-based interventions,
willing to collaborate to deliver lifestyle interventions outside
the typical clinical health setting (37).
Similar to this study, participants in the COPUS Trial (41)
stated that they enjoyed engaging in a “real-world” exercise
setting and felt they were treated by exercise instructors as
“normal”. Instructors and student interns engaged with clients
during exercise providing instruction and motivational support;
this also provided opportunities to monitor participant progress
and engagement during the session. SHAPE participants could
arrange to meet exercise buddies to use fitness facilities and
follow their individualized exercise program outside of the
formal SHAPE sessions. Involving University students inOctober 2020 | Volume 11 | Article 577691
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increased the mental health awareness of student instructors,
and was evaluated positively by SHAPE participants, several of
whom expressed an interest in becoming peer support workers
on the SHAPE program or pursuing higher education study
opportunities themselves. A combined exercise and health
behavior group-based intervention appears to be most
impactful for young people with FEP based on published
studies to date (16, 17, 21, 24).
Program Challenges
Initially, attitudes toward the intervention within EIP service
were mixed as several team members questioned whether this
should be a treatment priority or an appropriate focus for the
team, perceiving it as a primary care responsibility. Training
sessions with EIP staff were provided by the program team about
the importance of early physical health, their role in promoting
good physical health (including comprehensive repeat physical
health assessment and monitoring), and the need to increase
referrals to the SHAPE program and to other intervention
services including smoking cessation programs and sexual
health services.
Changes to clinical practice were required to ensure
standardized monitoring of physical health including: 1)
improved physical health monitoring and intervention through
comprehensive physical health checks, 2) monitoring, recording
and evaluating physiological changes that increase risk of CVD
and diabetes, 3) early identification of individuals at high risk for
cardiometabolic disorders and referral for specialist intervention,
and 4) increased communication with general practitioners to
improve physical health care planning. These observations are
not unique, Blythe and White (95) reported that London-based
mental health nurses (n = 585) received limited educational
support in their role to monitor physical health and poor
communication between primary and secondary care services
impacted their ability to address physical health needs of
SMI patients.
Program Costs and Cost Effectiveness
Currently, there is a lack of cost effectiveness research
examining supervised exercise programs in SMI, apart from
two large scale unsuccessful intervention trials which reported
no evidence for their cost effectiveness (28, 96). No EIP studies
to date have reported on cost effectiveness. However, similar
programs for diabetes, heart disease, and depression have
shown exercise programs can produce large economic
benefits (97).
Total setup and annual delivery costs of delivering a 12-week
SHAPE program to 4 cohorts per year at 4 locations
simultaneously within the County (total reach = 125–150
patients) were estimated at £40,000 pa (2015 prices) at an
approximate cost of £260–£400 per person per annum.
Implementation costs included staff training, recruitment of a
program lead, SHAPE package and materials, venue costs,
speakers for educational sessions and transport costs. This
model allowed for sustainable delivery and for SHAPE to beFrontiers in Endocrinology | www.frontiersin.org 14delivered as one element in an integrated NHS mental and
physical health care package.
Weight maintenance and reduction has been linked to
improved life expectancy of 2–3 years and a reduced QALY
cost if patients can avoid a 7% weight gain (15, 78). Equally,
changes in eating, PA, smoking, and alcohol use reported by
several participants at 12-month follow-up could potentially
increase life expectancy by almost 5 years (89). This does
assume participant engagement and program retention and for
reported outcomes to be maintained long enough to benefit from
the health states associated with them. Based on this, the
estimated intervention costs and QALYs improvements linked
to SHAPE outcomes would suggest that the SHAPE program is
likely to be a cost-effective and value for money intervention.
More research is needed on cost effectiveness of physical health
intervention programs in FEP considering the unique barriers
young people face when engaging in an exercise and health
behavior intervention (31, 32) and their impact on successful
program engagement, adherence, and likely outcomes.
Program Sustainability and Scale Up
Implementation and sustainability in a real-world setting eludes
the majority of intervention studies to date and requires greater
integration of an intervention program within the organization
in which it is being implemented (coordination of resources,
staffing) as well ongoing resourcing to sustain programs in the
long term beyond pilot intervention trials (34, 98). Our program
was successfully integrated into existing UK National Health
Service (NHS) care to provide service users education and
support to achieve sustainable health behavior change.
SHAPE data was used to make a case for investment and
funding for the program to be scaled up and delivered in multiple
sites countywide. SHAPE was formally commissioned and has
since been rolled out across the County with SHAPE programs
running weekly in six localities across the catchment area. The
SHAPE model was included as a good practice case example on
the NICE shared learning database (99) and adopted by other
EIP teams regionally and nationally. The SHAPE physical health
lead nurse role has been extended for the whole NHS Trust and a
permanent exercise coach was employed to support the SHAPE
program. Training on how, when and what to screen when
undertaking routine physical health monitoring and the
importance of a consistent, unified approach to collecting
physiological measures, awareness of risk indicators, and what
kinds of interventions are appropriate in response to risks
identified has been rolled out for mental health professionals
locally. Online lifestyle and nutrition education materials and a
manual and toolkit were made available on a bespoke SHAPE
program website.
Strengths and Limitations
A “real-world”, effectiveness-implementation hybrid approach to
program evaluation was designed to enhance external validity
and transfer to other “real-world” settings, which has been
problematic with previous randomized controlled trials. Unlike
other EIP physical health intervention studies which haveOctober 2020 | Volume 11 | Article 577691
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“treatment as usual” FEP sample from the same service (24), the
KBIM intervention was also embedded into routine EIP care (21)
and similarly chose to draw on a comparison group recruited
from another New South Wales EIP service who received
“standard care”. Without a matched control group, we cannot
definitively attribute changes reported to the SHAPE
intervention, particularly when delivered as one element in a
multi-component EIP routine care package, although participant
focus group feedback and self-reported health behavior and
exercise changes were attributed by participants to SHAPE
program participation.
The participant sample is relatively small, although it is the
largest intervention sample of all published EIP studies to date.
Access to health records was limited to those participants who
provided informed consent, so findings may not be reflective of
all SHAPE participants or all people with early psychosis under
the care of the EIP service. Current study findings are based on
outcomes entirely from one EIP service in one geographical area
and thus, a sample bias might exist. The area from which the
sample was drawn is a mixed urban/rural county with varying
levels of economic and social deprivation which might impact on
engagement, adherence, and needs of participants. Moreover, it
is possible that participants who declined assessments (and not
included in the data sample) might have more risk factors for
poor physical health linked to their circumstances and perhaps
be less likely to report similar views to program participant peers.
Equally, program participants might be more likely to engage
with assessments and report benefits.
The results of the clinical data should be interpreted in the
context of several important limitations. Measures employed in
the study evaluation were restricted to those measures carried
out at baseline and repeated annually as part of routine physical
health assessment and review processes. Health risk behaviors
were only routinely re-assessed as part of an annual physical
health review and not available at 12-week post-intervention.
Clinical measures from the two EIP teams were not always
directly comparable with one another as there was no
standardized approach in requesting clinical screening data at
baseline or at 1 year into service. General practitioners made
individual decisions regarding which blood tests were performed
making it difficult to compare across teams and timepoints. To
ensure a consistent, unified approach to collecting physiological
measures (i.e., tests performed and timing) requires agreement
across EIP teams in conjunction with primary care services.
Similarly, there was some attrition in the 12-month follow-up
data sample where health records were not accessible to extract
12-month follow-up physical health review outcomes. Data on
antipsychotic exposure, adherence to antipsychotic medication,
as well as any changes in antipsychotic medication type and
dosage during the 12-month follow-up period were not captured
and may be potential confounds influencing study findings.
A semi-structured focus group may have constrained
participant responses by encouraging conformity and strategic
biases and inhibiting participants from talking about issues that
were perceived as particularly relevant to them, rather than aFrontiers in Endocrinology | www.frontiersin.org 15priori issues chosen by the program team. Some focus group
participants may have been reluctant to talk about potentially
sensitive topics in relation to their experience of other
participants, negative consequences, or personal information in
relation to impact on weight or health behavior in a group
discussion setting. Participants separately consented to
participate in the focus groups which not all participants chose
to attend. Themes identified in the focus group transcript may be
subject to bias and not necessarily reflect the experiences of all
SHAPE participants or dropouts. Focus groups were conducted
by the teammembers known to some participants within the EIP
service. This may have led to an investigator bias in the way
questions were asked and elaborated and a desirability bias on
the part of participants affecting their responses. Transcripts
were examined for main themes and may be subject to inherent
investigator bias as the authors were involved in program design
and evaluation.
Considerations and Learning for Future
Physical Health Intervention Programs
Future intervention program design should consider combining
exercise with lifestyle interventions that are grounded in
behavior change theory to foster self-efficacy and improve
perceived competence of program participants. Effective
implementation requires close alignment between researchers,
health care systems, and community providers to develop a
sustainable approach and ensure continued implementation
and delivery in routine healthcare. Intervention programs need
to be of sufficient duration to provide practical skills for exercise,
healthy eating, building self-efficacy and autonomy as well as an
individualized transition strategy to sustain program outcomes.
Consideration of the unique barriers, particularly funding
concerns, that young people describe when engaging in an
exercise and lifestyle intervention may be critical to successful
program engagement and adherence.CONCLUSION
At the time of diagnosis, SHAPE participants were already at an
increased risk for cardiometabolic disorders due to elevated
clinical markers and unhealthy health behaviors. The findings
suggest SHAPE supported young people with FEP to attenuate
their physical health risk following a 12-week combined exercise
and health behavior intervention which was sustained at 12-
month follow-up. Positive health behavior changes reported at
12-month follow-up may have mediated the sustained weight
maintenance and improved physical health outcomes observed.
Physical health interventions are needed early in the treatment
process to address the increased risk for cardiometabolic
disorders in individuals recently diagnosed with FEP. Using an
effectiveness-implementation hybrid model, to design and
evaluate a combined exercise and health behavior intervention
for FEP patients in a real-world setting, may enhance program
effectiveness and subsequent uptake of effective interventions
into routine care.October 2020 | Volume 11 | Article 577691
Smith et al. Effectiveness and Implementation of SHAPEDATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by University of Worcester Research Ethics Committee
(REC approval number: UWEC2014JS1). The patients/participants
provided their written informed consent to participate in this study.AUTHOR CONTRIBUTIONS
JS, LG, MB, BW, and EB devised the original protocol. JS, LG,
MB, BW, EB, JB, RD, RH-S, and DH refined the protocol. JS was
the chief investigator and oversaw the study. MB and RH-S
recruited participants. MB and LG were responsible for study
procedures. JS, BW, EB, JB, RD, DH, and RH-S provided
feedback on the recruitment methods and helped refine the study
procedures. MB, JB, RD, RH-S, and BW delivered the intervention.
LG did the quantitative data analysis. JS did the qualitative data
analysis. JS oversaw the data analysis. The writing team consisted of
JS and LG who drafted and edited the report manuscript. DH and
EB proofread the final manuscript. JS, LG, MB, BW, EB, JB, RD,Frontiers in Endocrinology | www.frontiersin.org 16RH-S, and DH critically reviewed drafts of the manuscript for
important intellectual content. All authors contributed to the article
and approved the submitted version.FUNDING
The Health Foundation: Shine Award 2014 and Spreading
Improvement Award 2015; Postcode Anywhere, Diglis Basin,
Worcester provided small grant funding for participant
equipment (pedometers, water bottles, and tape measures).ACKNOWLEDGMENTS
The SHAPE program was supported by the Health Foundation,
an independent charity working to improve the quality of
healthcare in the UK. We would like to thank all of the
stakeholders: Worcestershire Early Intervention Service,
Worcestershire Health and Care NHS Trust, University of
Worcester McClelland Centre, SHAPE participants and carers,
health care professionals, University staff and students who took
part in or supported the program. We would also like to thank
Dr. David Shiers for his support and advice when establishing the
SHAPE Program and his valuable comments and feedback on
earlier manuscript drafts.REFERENCES
1. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P,
et al. Prevalence, incidence and mortality from cardiovascular disease in
patients with pooled and specific severe mental illness: a large-scale meta-
analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry
(2017) 16:163–80. doi: 10.1002/wps.20420
2. Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics
result in weight gain: a meta-analysis. PloS One (2014) 9(4):e94112.
doi: 10.1371/journal.pone.0094112
3. Balõts ̌ev R, Haring L, Koido K, Leping V, Kriisa K, Zilmer M, et al.
Antipsychotic treatment is associated with inflammatory and metabolic
biomarkers alterations among first-episode psychosis patients: A 7-month
follow-up study. Early Interv Psychiatry (2019) 13(1):101–09. doi: 10.1111/
eip.12457
4. Bushe C, Taylor M, Haukka J. Mortality in schizophrenia: a clinical endpoint.
J Psychopharmacol (2010) 24:17–25. doi: 10.1177/1359786810382468
5. Galletly CA, Foley DL, Waterreus A, Watts GF, Castle DJ, McGrath JJ, et al.
Cardiometabolic risk factors in people with psychotic disorders: the second
Australian national survey of psychosis. Aust NZ J Psychiat (2012) 46(8):753–
61. doi: 10.1177/0004867412453089
6. Pillinger T, D’Ambrosio E, McCutcheon R, Howes OD. Is psychosis a
multisystem disorder? A meta-review of central nervous system, immune,
cardiometabolic, and endocrine alterations in first-episode psychosis and
perspective on potential models. Mol Psychiatry (2019) 24(6):776–94. doi:
10.1038/s41380-018-0058-9
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